Arcutis Biotherapeutics Inc (ARQT) Stock Analysis

Arcutis Biotherapeutics Inc (ARQT) is a publicly traded company in the HEALTHCARE sector. It trades at $20.79, carries a market capitalization of $2.69B. This page summarizes the public market data, fundamentals, and frequently asked questions for ARQT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $20.79
• Market Cap: $2.69B
• EPS: $-0.02
• 52-Week High: $31.77
• 52-Week Low: $12.72

Market Sentiment

Arcutis Biotherapeutics Inc currently has a Bullish sentiment score of 0.16.

GNG Research Analysis

GNG Research scores Arcutis Biotherapeutics Inc (ARQT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ARQT.

Frequently Asked Questions

Does ARQT pay dividends?

Arcutis Biotherapeutics Inc (ARQT) does not currently pay a regular dividend.

What is ARQT's market cap?

Arcutis Biotherapeutics Inc (ARQT) has a market capitalization of $2.69B with a current stock price of $20.79.